iHuman Inc. Files 6-K Report
Ticker: IH · Form: 6-K · Filed: Sep 18, 2025 · CIK: 1814423
| Field | Detail |
|---|---|
| Company | Ihuman INC. (IH) |
| Form Type | 6-K |
| Filed Date | Sep 18, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, filing, press-release
TL;DR
iHuman Inc. filed a 6-K on 9/18/25 with a press release attached.
AI Summary
iHuman Inc. filed a Form 6-K on September 18, 2025, reporting for the month of September 2025. The filing includes a press release as Exhibit 99.1. Vivien Weiwei Wang, Director and Chief Financial Officer, signed the report on behalf of the company.
Why It Matters
This filing indicates ongoing reporting activity for iHuman Inc., which is standard for publicly traded companies and provides updates to investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other periodic information, not material financial changes.
Key Players & Entities
- iHuman Inc. (company) — Registrant
- Vivien Weiwei Wang (person) — Director and Chief Financial Officer
- September 18, 2025 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose to any stock exchange on which its securities are traded.
What is included in this specific 6-K filing?
This filing includes Exhibit 99.1, which is a Press Release.
Who signed this report on behalf of iHuman Inc.?
The report was signed by Vivien Weiwei Wang, Director and Chief Financial Officer.
What is the principal executive office address for iHuman Inc.?
The principal executive offices are located at Tower 306, No. 86 Beiyuan Road, Chaoyang District, Beijing 100101, People's Republic of China.
What is the SEC file number for iHuman Inc.?
The SEC file number for iHuman Inc. is 001-39591.
Filing Stats: 149 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-09-18 07:08:02
Filing Documents
- tm2526441d1_6k.htm (6-K) — 11KB
- tm2526441d1_ex99-1.htm (EX-99.1) — 190KB
- tm2526441d1_ex99-1img01.jpg (GRAPHIC) — 2KB
- 0001104659-25-091019.txt ( ) — 205KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. iHuman Inc. By : /s/ Vivien Weiwei Wang Name : Vivien Weiwei Wang Title : Director and Chief Financial Officer Date: September 18, 2025